CN1186042C - Chinese medicine composition for curing AIDS and its preparation mehtod - Google Patents
Chinese medicine composition for curing AIDS and its preparation mehtod Download PDFInfo
- Publication number
- CN1186042C CN1186042C CNB011449519A CN01144951A CN1186042C CN 1186042 C CN1186042 C CN 1186042C CN B011449519 A CNB011449519 A CN B011449519A CN 01144951 A CN01144951 A CN 01144951A CN 1186042 C CN1186042 C CN 1186042C
- Authority
- CN
- China
- Prior art keywords
- aids
- parts
- chinese medicine
- medicine composition
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000030507 AIDS Diseases 0.000 title claims abstract description 58
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000011282 treatment Methods 0.000 claims abstract description 24
- 241000190633 Cordyceps Species 0.000 claims abstract description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 13
- 235000008434 ginseng Nutrition 0.000 claims abstract description 13
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 235000021551 crystal sugar Nutrition 0.000 claims abstract description 9
- 241000132011 Atractylodes lancea Species 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 7
- 238000004821 distillation Methods 0.000 claims abstract description 4
- 208000011580 syndromic disease Diseases 0.000 claims description 21
- 241000208340 Araliaceae Species 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 241000287828 Gallus gallus Species 0.000 claims description 7
- 235000013330 chicken meat Nutrition 0.000 claims description 7
- 238000005192 partition Methods 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 238000003828 vacuum filtration Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 241000545442 Radix Species 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 15
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 3
- 241000700605 Viruses Species 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 238000004088 simulation Methods 0.000 abstract description 3
- 238000001694 spray drying Methods 0.000 abstract description 3
- 238000012795 verification Methods 0.000 abstract 2
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000189004 Caragana arborescens Species 0.000 abstract 1
- 235000014022 Caragana arborescens Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 240000007049 Juglans regia Species 0.000 abstract 1
- 235000009496 Juglans regia Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 210000004698 lymphocyte Anatomy 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 208000036142 Viral infection Diseases 0.000 description 5
- 210000001185 bone marrow Anatomy 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 230000009385 viral infection Effects 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 201000000849 skin cancer Diseases 0.000 description 4
- 201000008261 skin carcinoma Diseases 0.000 description 4
- 108010002350 Interleukin-2 Proteins 0.000 description 3
- 102000000588 Interleukin-2 Human genes 0.000 description 3
- 102000010909 Monoamine Oxidase Human genes 0.000 description 3
- 108010062431 Monoamine oxidase Proteins 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 206010002660 Anoxia Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 208000029462 Immunodeficiency disease Diseases 0.000 description 2
- 102100037850 Interferon gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- 102000000589 Interleukin-1 Human genes 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000011284 combination treatment Methods 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003714 granulocyte Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000007813 immunodeficiency Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000009286 sanguis draxonis Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 244000000383 Allium odorum Species 0.000 description 1
- 235000018645 Allium odorum Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000006793 Artemisia stelleriana Nutrition 0.000 description 1
- 244000252230 Artemisia stelleriana Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 240000009087 Crescentia cujete Species 0.000 description 1
- 235000005983 Crescentia cujete Nutrition 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000533849 Gleditsia Species 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
- 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
- 240000005308 Juniperus chinensis Species 0.000 description 1
- 235000009797 Lagenaria vulgaris Nutrition 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- -1 Radix Scutellariae Substances 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000006413 coastal sagewort Nutrition 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000009806 pulsatillae Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a Chinese medicine composition for treating AIDS and a preparation method thereof, which belongs to medical configuration articles containing Chinese medicine material. The Chinese medicine composition is prepared from astragalus root, caragana arborescens, dried tangerine peel, atractylis lancea, english walnut fruit septum, Chinese date, red glossy ganoderma, ginseng and crystal sugar through twice decoction, the materials are filtered, filtered solutions are combined, fine powder of tuckahoe, cordyceps and saute white atractylodes rhizome is added, and a concentrated solution is made into powder through spray drying after low-temperature reduced-pressure distillation and concentration. The Chinese medicine composition is a true natural medicine which has significant curative effect and no side effect and can restore organism immunity damaged by AIDS viruses and effectively inhibit the AIDS viruses through identification of simulation experiments of animals and clinic treatment verification of AIDS patients; the present invention has significant curative effect through treatment verification of 241 clinic AIDS examples and patients with AIDS relevant disease symptoms, and the total effective rate reaches 95.8%; the present invention has no side effect when taken for a long term and has the advantages of high safety and reliability.
Description
Technical field
The invention belongs to the medical configuration product that contain the Chinese medicine material, particularly a kind of Chinese medicine composition for the treatment of acquired immune deficiency syndrome (AIDS) and preparation method thereof.
Background technology
Acquired immune deficiency syndrome (AIDS) is a kind of day after tomorrow of an acquired immune deficiency syndrome (AIDS), on very long medical history, does not also have and can so shake the whole world, and causes various countries' common concern, and drops into the disease that a large amount of human and material resources and financial resources are prevented and treated.
Treated the medicine of acquired immune deficiency syndrome (AIDS) in the past,, belonged to nucleoside medicine, had the similar pharmacological action of single antiviral, toxicity was in various degree all arranged, especially to the toxicity of bone marrow as AZT, ddc, ddi, d4T, 3TC etc.The medicine that is used for the treatment of acquired immune deficiency syndrome (AIDS) at present, it is limited generally to have curative effect, costs an arm and a leg, and toxic and side effects is big, is easy to generate chemical sproof shortcoming.
The application Chinese medicine and pharmacy is prevented and treated acquired immune deficiency syndrome (AIDS) and is also caused extensive concern, has the various components of better effects and the preparation of processing method and comes out one after another.
Chinese patent 1183298 discloses " a kind of capsule for the treatment of acquired immune deficiency syndrome (AIDS) and preparation method thereof ", and this capsule is chosen Herba Epimedii, Rhizoma Curcumae, Rhizoma Osmundae, Radix Et Rhizoma Rhei, the Radix Stemonae, Artemisia anethoicles Mattf, Radix Platycodonis, Herba Houttuyniae, Chinese juniper beach wormwood, Fructus Tsaoko, Cordyceps, calcium carbonate, allicin, the new element of Radix Glycyrrhizae etc. and is prepared from.
Chinese patent 1207323 discloses " a kind of medicine for the treatment of acquired immune deficiency syndrome (AIDS) and preparation method thereof ", it mainly by Hedyotidis Diffusae, Aloe, Rhizoma Polygoni Cuspidati, Indigo Naturalis, Radix Sophorae Tonkinensis, fragrant-flowered garlic seed, Ganoderma, Flos Lonicerae, Rhizoma Smilacis Glabrae, Radix Scutellariae, Radix Ginseng, Radix Glycyrrhizae, Bulbus Allii, Fructus Caricae, etc. Chinese medicine form.
Chinese patent 1181255 discloses " a kind of medicine for the treatment of acquired immune deficiency syndrome (AIDS) ", and it is Semen Strychni (processed), Pyritum, Scorpio, Scolopendra, Sanguis Draxonis, Radix Trichosanthis, Fin Mustetus manazo, berberine to be concocted grind into powder, the full decocting extracting juice of calabash courd, after add starch and make pill.
That Chinese patent 1122236 discloses is a kind of " medicine of treatment acquired immune deficiency syndrome (AIDS) and preparation method thereof ", be adopt Cacumen Securinegae Suffruticosae, Sanguis Draxonis, the Radix Astragali, Radix Codonopsis, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Cortex Acanthopancis, Radix Polygoni Multiflori, Fructus Jujubae, Caulis Spatholobi, Fructus Rosae Laevigatae, Fructus Trichosanthis shell, the Radix Pulsatillae, Radix Scutellariae, Radix Isatidis, Fructus Gleditsia rice, etc. Chinese crude drug make.
1159330 of Chinese patents disclose a kind of " Chinese medicine ointment for AIDS ", and it is made by Radix Codonopsis, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae Preparata, the Radix Astragali, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Ah foot, the Cortex Eucommiae, Radix Dipsaci, Fructus Corni, Fructus Lycii, Fructus Rubi, Rhizoma Alismatis, tween, sodium benzoate, crystal sugar.
Summary of the invention
Prior art medicine toxicity, side effect is big in order to solve for this Chinese medicine, the inapparent technical problem of curative effect and a kind of Chinese medicine composition for the treatment of acquired immune deficiency syndrome (AIDS) and preparation method thereof is provided.
This Chinese medicine is made by following raw materials in weight portion:
Radix Ginseng 10-30 part Radix Astragali 20-60 part tree chicken 10-30 part
Pericarpium Citri Reticulatae 15-45 part Atractylodes lancea (Thunb.) DC. 20-60 part Poria 15-45 part
Partition in Fructus Juglandis 6-20 part Fructus Jujubae 50-100 part
Cordyceps (Cordyceps) 15-60 part
Red ganoderma 15-60 part Rhizoma Atractylodis Macrocephalae (parched) 20-80 part crystal sugar 20-60 part.
This Chinese medicine is made by following raw materials in weight portion:
30 parts of 30 parts of trees of 30 parts of Radixs Astragali of Radix Ginseng chickens
15 parts in 20 parts of Poria of 10 parts of Atractylodes lancea (Thunb.) DC. of Pericarpium Citri Reticulatae
50 parts in 6 portions of Fructus Jujubaes of Partition in Fructus Juglandis
Cordyceps (Cordyceps) 15-60 part
30 parts in 20 portions of crystal sugar of 20 parts of Rhizoma Atractylodis Macrocephalae (parched)s of red ganoderma.
This preparation method of Chinese medicine is:
Take by weighing Radix Astragali 20-60 part, tree chicken 10-30 part, Radix Ginseng 10-30 part, Fructus Jujubae 50-100 part, Pericarpium Citri Reticulatae 15-45 part, Atractylodes lancea (Thunb.) DC. 20-60 part, Partition in Fructus Juglandis 6-20 part, Cordyceps (Cordyceps) 20-60 part, red ganoderma 15-60 part, Radix Ginseng 10-30 part, Fructus Jujubae 50-100 part by weight, clean up back cold water soak 1-2 hour, boil with the immersion decocting, for the first time amount of water is 6 times of above component, decoct Radix Ginseng, Fructus Jujubae earlier, 1.5-2 hour, adding other components and crystal sugar 20-60 part, decocted 30-45 minute; Decocting liquid is standby through vacuum filtration; The water that medicinal residues add 3 times of weight portions carries out the 2nd decoction 0.5-1 hour, the vacuum filtration slagging-off; Merge filtrate twice, Poria 15-45 part, Cordyceps (Cordyceps) 15-60 part, Rhizoma Atractylodis Macrocephalae (parched) 20-80 part of adding 120 mesh sieves stir, and it is 1: 20 that the low-temperature reduced-pressure distillation is concentrated into relative density; Again with the spray-dried one-tenth powder of concentrated solution.
This Chinese medicine not only has killing, suppresses the effect of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), and the most outstanding be to repair, to rebuild impaired body immune system, thereby can treat acquired immune deficiency syndrome (AIDS) effectively, centering, patients with terminal still have significant curative effect.Because this compositions has and keeps and promote CD
+ 8Mediation ctl response level, thereby have the viral infection of preventing AIDS, make HIV the infected's long term maintenance at disease-free state.
This Chinese medicine is identified by the animal simulation experiment and is clinical in HIV sufferers treatment checking, is that a kind of evident in efficacy can making by the destructive immunity of organism of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) recovers really, and can effectively suppresses the natural drug that has no side effect of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus).
Zhi Bei medicine is through clinical 241 routine acquired immune deficiency syndrome (AIDS) and acquired immune deficiency syndrome (AIDS) associated conditions patient's treatment checking like this, and this medicine has significant curative effect, total effective rate 95.8%.Take without any side effects, safe and reliable for a long time.
This medicated powder incapsulates and is capsule, every capsules 0.3 gram; The sealing bag of packing into is an electuary, every bag 12 gram.
Usage and consumption:
Capsule: obey the 3-6 grain after meal half an hour, take every day continuously, and every three months is a course of treatment, warm boiled water.
Electuary: respectively obey 1/3 bag early, middle and late half an hour after meal, warm boiled water.
Concrete enforcement side takes by weighing 3 kilograms of the Radixs Astragali, 3 kilograms of chickens of tree, 3 kilograms of Radix Ginsengs, 5 kilograms in Fructus Jujubae, 1 kilogram of Pericarpium Citri Reticulatae, 2 kilograms of Atractylodes lancea (Thunb.) DC., 0.6 kilogram of Partition in Fructus Juglandis, 2 kilograms of red ganodermas, clean up cold water soak 2 hours under the room temperature condition of back, boil with the immersion decocting, for the first time amount of water is 6 times of above component, promptly 117.6 kg of water decoct Radix Ginseng, Fructus Jujubae earlier, 1.5 hour, add 3 kilograms in other component and crystal sugar again, decocted 45 minutes; Boil with big fire earlier, transfer little fire to and keep slight boiling condition, decocting liquid is standby through vacuum filtration; In addition medicinal residues are added 3 times of amounts promptly 58.8 kilograms water carry out the 2nd time and decocted the vacuum filtration slagging-off 1 hour; Merge filtrate twice, added 1.5 kilograms in Poria, 1.5 kilograms of Cordyceps (Cordyceps), 2 kilograms of the Rhizoma Atractylodis Macrocephalae (parched)s of 120 mesh sieves, stir, it is 1: 20 that the low-temperature reduced-pressure distillation is concentrated into relative density; Again concentrated solution is injected in the spray drying tower, adopt spray drying method, at shower nozzle compressed air [3982-490Kpa (4-5Kg/CM
2)] medicine liquid spray is dried to powder, incapsulate every 0.3 gram; The packaging bag of packing into restrains for every bag 12.
The pharmacological action of this Chinese medicine:
The pharmacological action of this Chinese medicine is to repair, rebuild impaired body immune system, stimulates the interior stem cell of bone marrow to generate new granular lymphocyte and NK cell: to recover thymus function, strengthen the inductive lymphproliferation response of mitogen, promote propagation, the differentiation of T cell; The propagation and the differentiation of energy irritation cell toxicity T cell impel the repressed T4 of body, Tc activation recovering; Promote the mononuclear phagocyte function, promote the generation of IL-1, IL-2 and IFN-γ (interferon), increase OKT4/IL-2 and express the cell number of IL-2 receptor; Body cell multiplication had facilitation; Damage has protective effect to lymphocyte DNA; Has anti-modificator gene mutation effect; Adjust immune status, the immune response system that is changing in the body is produced balanced action; To the very strong inhibitory action of duplicating of HIV (human immunodeficiency virus), suppress the RT activity of virus; Stop HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) in conjunction with target cell, stop by the cell fusion of the cell of viral infection with contiguous uninfection; Suppress the cellular replication of AIDS viral infection, and can kill the cell of AIDS viral infection, and not infected normal cell is protected.
The animal simulation experiment
The result shows that this compositions is suppressed PFC (plaque forming cells), SRFC (the specificity rosettes of mice to normal mouse and immunity
Form) and DTH (delayed is super quick) test, tangible immunologic enhancement all shown.
Normal mouse bone marrow stem cell after low dose of gamma-rays is handled there is tangible promotion proliferation function, promote the formation of new granular lymphocyte, granulocyte monocytic series colony forming unit (CFU-GM), the medulla hematopoietic system function is also had comprehensive facilitation.Under the condition that the hemopoietic function that injection causes to cyclophosphamide (CY) obviously suppresses, can promote mice peripheral blood leucocyte, granulocyte, bone marrow nucleated cell, CFU-GM, lymphocyte to return to normal level.Point out this medicine to have the pharmacological action of reparation, reconstruction immunodeficiency.
This compositions can increase the auxiliary lymphocyte of T, CTL cell, NK cell number and the vigor that immunity is suppressed mice.What deserves to be explained is that especially many experiments report confirms, in asymptomatic HIV the infected's body, can measure the specific CTL of multiple anti-H IV, comprise anti-env, gag/pol, RT, P17, P24, p41, and proteic Specific CTL Cells such as nef.Experiment is also found to carry and do not send out the patient and isolate CD at long-term HIV
8Cell, or after effectively controlling the CTL cell function, the HIV replication capacity is just in rising trend.Experiment has also proved at external specific CTL can kill the CD that is infected by HIV effectively
4Cell, and can kill and wound the macrophage that HIV infects.This shows that ctl response is not only providing important anti-infective protection to the infected not, but also can control duplicating and lethal effect of HIV after infection.Thereby the prompting said composition is by repairing, rebuilding patient's immunodeficiency, keeps and promotes body CD
8 +Mediation ctl response level reaches the infection that prevents AIDS, and HIV is being infected be maintained in disease-free state, and to the immune pharmacological action of repairing and killing HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) of HIV sufferers.Can improve generation level and the biological activity of lymphokine IL-1 and IL-2, IFN-γ (interferon).
It is heavy to increase mice spleen, and directly promotes the propagation of T, bone-marrow-derived lymphocyte, promotes the phagocytic activity of macrophage, strengthens the protective effect to the lymphocyte DNA damage, has anti-modificator gene mutation effect.
Can improve immunity and be suppressed anakinetomer content in the mouse red blood cell, reduce the blood number of free radical, improve SOD (superoxide dismutase) vigor in the tissue, increase blood plasma GSH content, reduce MAO-B (monoamine oxidase, MAO), and can improve the anti-anoxia ability of experiment mice from integral level, keep anakinetomer normal contents in the anoxia heart, the cerebral tissue, keep homergy to regulate, improve oxygen content in the blood, reduce oxygen consumption, strengthen myocardial contraction and point out this medicine to have comprehensive enhancing physiological function, improve the effect of body constitution and vitality.
Mice can't measure half lethal dose (LD in studies on acute toxicity
50), under 200 times of the suitable human body taking doses of mice taking dose, still can not cause dead mouse.In subacute toxicity research, to give continuously and raise 6 months mice weight increase, other every tests are all similar to matched group.
Clinical case is summed up
Clinical case data (one):
This organizes in 9 examples, full-blown AIDS patient be from June in August, 1994 to nineteen ninety-five in Sydney, AUS, abandon, stop using Western medicine voluntarily and accept this combination treatment.All detect before the treatment and show the HIV positive, meet WTO becoming the case definition of human AIDS through ELISA.Wherein age of onset 23-55 year, be male Australian, the course of disease 3 examples more than 10 years, 2 examples more than 5 years, 4 examples below 3 years, KS (skin carcinoma) 7 examples (88.9%) that wherein occur together, PCP (companion's intractable cough) 2 examples (22.3%) CD
+ 4Cell number 0.089-0.39 * 10
9/ L, average 0.175 * 10
9/ L is in clinical being diagnosed as, full-blown AIDS sends out the patient.Clinical symptoms feature: weak 9 examples (100%), lymph enlargement 6 examples (66.7%), low grade fever 2 examples (22.3%) that continue, indigestion and loss of appetite 4 examples (44.5%), diarrhoea 1 example (11%), candidiasis 1 example (11%).Pain (inclined to one side head, abdomen, skeleton all over the body) 6 examples (66.7%).
The result: all 9 routine patients are after 1-9 the course of treatment, and all mitigation symptoms eliminations gradually of described symptom are got well before the treatment, and body weight has all increased 0.5-4.5Kg, average 1.5Kg, CD
+ 4Cell number improves 0.05-0.15 * 10
9/ L, wherein the part patient detects HIVP
24Antigen is eliminated fully, and total effective rate reaches 95.8%.
The treatment of skin carcinoma: the acquired immune deficiency syndrome (AIDS) skin carcinoma that occurs together is a kind of true property malignant tumor of endotheliocyte, and add up internal organs (liver, intestines and stomach, lung and lymph node) generally to be considered to the course of disease anxious more, the case fatality rate height, the current that lives forever most 36 months, average survival period 18 months, the treatment difficulty, unrooted removes therapy.And this group is accepted 7 examples for medical treatment and is all met U.S. CDC and determine diagnostic criteria, and the concurrent skin carcinoma of determining according to pathology detection of acquired immune deficiency syndrome (AIDS).The clinical manifestation skin lesion is extensive, and the brown macule that the visible range degree is different, hard speckle and the hard lump that swells did not wait in course of disease 2.5-35 month, and wherein 1 example is recidivist behind the radiotherapy.The state of an illness commentariess on classics of getting better in general 1 week, 1-3 month focus is by hard, thick deliquescing gradually, thin, and complete obiteration at last reaches healing.
Clinical case data (two):
This organize 16 routine patients be from year May in April, 1992 to 1999 successively in China, Australia, Canada, never or be reluctant to take Western medicine, only accept the AIDS virus carrier of this combination treatment merely.All detect the HIV positive, meet the Center for Disease Control (CDC) and be diagnosed as AIDS viral infection about acquired immune deficiency syndrome (AIDS) clinical case definition and do not send out the patient through the ELISA method.Wherein male 14 examples, women 2 examples, age 21-48 year, average 31.6 years old, infection time 2 examples more than 10 years, 8 examples, 6 examples below 3 years more than 5 years.CD
+ 4Cell number 0.82-1.26 * 10
9/ L, average 0.96 * 10
9/ L.
The result: sick after visiting 3-5 generally through the treatment of 2-6 the course of treatment, the patient of sending out is not all arranged, CD
+ 4Cell number maintains normal level, and HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) is subjected to controlling effectively.
Claims (3)
1. Chinese medicine composition for the treatment of acquired immune deficiency syndrome (AIDS) is characterized in that making by following raw materials in weight portion:
Radix Ginseng 10-30 part Radix Astragali 20-60 part tree chicken 10-30 part
Pericarpium Citri Reticulatae 15-45 part Atractylodes lancea (Thunb.) DC. 20-60 part Poria 15-45 part
Partition in Fructus Juglandis 6-20 part Fructus Jujubae 50-100 part Cordyceps 15-60 part
Red ganoderma 15-60 part Rhizoma Atractylodis Macrocephalae (parched) 20-80 part crystal sugar 20-60 part.
2. Chinese medicine composition for the treatment of acquired immune deficiency syndrome (AIDS) is characterized in that making by following raw materials in weight portion:
30 parts of 30 parts of trees of 30 parts of Radixs Astragali of Radix Ginseng chickens
15 parts in 20 parts of Poria of 10 parts of Atractylodes lancea (Thunb.) DC. of Pericarpium Citri Reticulatae
15 parts of 50 parts of Cordyceps of 6 portions of Fructus Jujubaes of Partition in Fructus Juglandis
30 parts in 20 portions of crystal sugar of 20 parts of Rhizoma Atractylodis Macrocephalae (parched)s of red ganoderma.
3. preparation method for the treatment of the Chinese medicine composition of acquired immune deficiency syndrome (AIDS), it is characterized in that taking by weighing by weight Radix Astragali 20-60 part, tree chicken 10-30 part, Radix Ginseng 10-30 part, Fructus Jujubae 50-100 part, Pericarpium Citri Reticulatae 15-45 part, Atractylodes lancea (Thunb.) DC. 20-60 part, Partition in Fructus Juglandis 6-20 part, red ganoderma 15-60 part, clean up back cold water soak 1-2 hour, boil with the immersion decocting, for the first time amount of water is 6 times of above component, decoct Radix Ginseng, Fructus Jujubae earlier, 1.5-2 hour, add other components and crystal sugar 20-60 part again, decocted 30-45 minute; Decocting liquid is standby through vacuum filtration; The water that medicinal residues add 3 times of weight portions carries out the 2nd decoction 0.5-1 hour, the vacuum filtration slagging-off; Merge filtrate twice, Poria 15-45 part, Cordyceps 20-60 part, Rhizoma Atractylodis Macrocephalae (parched) 20-80 part of adding 120 mesh sieves stir, and it is 1: 20 that the low-temperature reduced-pressure distillation is concentrated into relative density; Again with the spray-dried one-tenth powder of concentrated solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011449519A CN1186042C (en) | 2001-12-25 | 2001-12-25 | Chinese medicine composition for curing AIDS and its preparation mehtod |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011449519A CN1186042C (en) | 2001-12-25 | 2001-12-25 | Chinese medicine composition for curing AIDS and its preparation mehtod |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1428166A CN1428166A (en) | 2003-07-09 |
| CN1186042C true CN1186042C (en) | 2005-01-26 |
Family
ID=4677907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011449519A Expired - Fee Related CN1186042C (en) | 2001-12-25 | 2001-12-25 | Chinese medicine composition for curing AIDS and its preparation mehtod |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1186042C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103446202B (en) | 2012-05-29 | 2018-11-06 | 江中药业股份有限公司 | A kind of composition and preparation method thereof of prevention and treatment AIDS |
| CN106074891A (en) * | 2016-07-29 | 2016-11-09 | 桂林淮安天然保健品开发有限公司 | Pharmaceutical composition for the treatment of acquired immune deficiency syndrome (AIDS) and preparation method thereof |
| CN105998143A (en) * | 2016-07-29 | 2016-10-12 | 桂林淮安天然保健品开发有限公司 | Anti-HIV pharmaceutical composition and preparation method thereof |
| CN106138162A (en) * | 2016-07-29 | 2016-11-23 | 桂林淮安天然保健品开发有限公司 | The pharmaceutical composition for the treatment of acquired immune deficiency syndrome (AIDS) |
-
2001
- 2001-12-25 CN CNB011449519A patent/CN1186042C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1428166A (en) | 2003-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703692A (en) | Chinese medicinal preparation for treating bone fracture and preparation method thereof | |
| JP2004161732A (en) | Herbal pharmaceutical compositions for the treatment of HIV / AIDS patients | |
| CN1476849A (en) | Medicine composition for promoting blood circulation and removing stasis | |
| WO2022227331A1 (en) | Composition for preventing rheumatoid arthritis, preparation method therefor, and application thereof | |
| CN1255181C (en) | Preparation of medicinal composition for nourishing | |
| CN101062339A (en) | Medicine for treating diabetes | |
| CN1256133C (en) | Antifatigue Chinese medicine composition and its prepn process | |
| CN1085099C (en) | Medicine for treating thyroid enlargement and thyroidism | |
| CN1186042C (en) | Chinese medicine composition for curing AIDS and its preparation mehtod | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN1490017A (en) | Medicines against rheunatoid and rheumatic diseases | |
| CN1086144C (en) | Capsule for tonifying kidney | |
| CN101199749A (en) | Chinese medicine for treating AIDS | |
| CN100366269C (en) | Chinese medicine for treating AIDS | |
| CN1058165C (en) | Chinese drugs for curing hepatitis B | |
| CN112891485B (en) | A traditional Chinese medicine composition for the treatment of new coronary pneumonia | |
| CN102488851B (en) | Drug for treating recurrent genital herpes and preparation method thereof | |
| CN101618156A (en) | Medicine composition for treating hepatitis B and preparation method thereof | |
| CN101199667A (en) | Chinese medicine for treating leukemia, aplastic anemia | |
| CN1279094A (en) | Oral medicine 'Feishu' and its preparing process | |
| CN1195541C (en) | Medicine combination for treating chronic hepatitis B | |
| CN104189770A (en) | Pharmaceutical composition for treating tuberculous pleuritis and preparation method thereof | |
| CN118416165B (en) | Chinese medicinal preparation for treating AIDS and its preparation method | |
| CN1126558C (en) | Medicine for treating kidney damage caused by immunological disease lupus erythematosus | |
| CN1150015C (en) | Medicine for treating leucocytopenia caused by lupus erythematosus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |